A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT06499350 · RECRUITING
Trial details
- NCT number
- NCT06499350
- Sponsor
- FindCure Biosciences (ZhongShan) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2026-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.